Fucoidan from Spatoglossum schröederi promotes B16-F10 malignancy features modulation and antimelanoma in vivo activities

FC Santi, GR Rossi, MB Reis, DM Leme, R Chammas… - Algal Research, 2023 - Elsevier
Although recent advances in targeted and immunotherapy, metastatic melanoma treatment
still poses as a challenge, with limited success and a variety of severe adverse effects …

Fucoidan from Spatoglossum schröederi promotes B16-F10 malignancy features modulation and antimelanoma in vivo activities

DL Bellan, IH Bini, FC Santi, GR Rossi… - Algal …, 2023 - ui.adsabs.harvard.edu
Although recent advances in targeted and immunotherapy, metastatic melanoma treatment
still poses as a challenge, with limited success and a variety of severe adverse effects …

Fucoidan from Spatoglossum schroederi promotes B16-F10 malignancy features modulation and antimelanoma in vivo activities

DL BELLAN, IH BINI, FC SANTI, GR ROSSI… - 2023 - observatorio.fm.usp.br
Although recent advances in targeted and immunotherapy, metastatic melanoma treatment
still poses as a challenge, with limited success and a variety of severe adverse effects …

[引用][C] Fucoidan from Spatoglossum schröederi promotes B16-F10 malignancy features modulation and antimelanoma in vivo activities

DL Bellan, IH Bini, FC Santi, GR Rossi… - Algal …, 2023 - espace.library.uq.edu.au

[引用][C] Fucoidan from Spatoglossum schroederi promotes B16-F10 malignancy features modulation and antimelanoma in vivo activities

DL Bellan, IH Bini, FC Santi, GR Rossi… - … -biomass biofuels and …, 2023 - repositorio.usp.br
ReP USP - Detalhe do registro: Fucoidan from Spatoglossum schroederi promotes B16-F10
malignancy features modulation and antimelanoma in vivo activities Home About USP Schools …

Fucoidan from Spatoglossum schroederi promotes B16-F10 malignancy features modulation and antimelanoma in vivo activities

DL BELLAN, IH BINI, FC SANTI… - Algal Research …, 2023 - observatorio.fm.usp.br
Although recent advances in targeted and immunotherapy, metastatic melanoma treatment
still poses as a challenge, with limited success and a variety of severe adverse effects …